Published in J Pain on August 01, 2003
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 1: general population. Can Fam Physician (2011) 2.69
Trends in use of opioids for chronic noncancer pain among individuals with mental health and substance use disorders: the TROUP study. Clin J Pain (2010) 2.54
Clinical characteristics of veterans prescribed high doses of opioid medications for chronic non-cancer pain. Pain (2010) 2.44
Trends in long-term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry (2009) 1.84
Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. Can Fam Physician (2011) 1.41
Depression and prescription opioid misuse among chronic opioid therapy recipients with no history of substance abuse. Ann Fam Med (2012) 1.35
Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev (2011) 1.15
Predictors of long-term opioid use among patients with painful lumbar spine conditions. J Pain (2009) 1.14
Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain (2010) 1.14
Long-term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med (2011) 1.11
Adherence to clinical guidelines for opioid therapy for chronic pain in patients with substance use disorder. J Gen Intern Med (2011) 1.11
Correlates of prescription opioid initiation and long-term opioid use in veterans with persistent pain. Clin J Pain (2013) 1.04
Chronic noncancer pain: characteristics of patients prescribed opioids by community physicians and referred to a tertiary pain clinic. Can Fam Physician (2011) 1.02
A preliminary study comparing methadone and buprenorphine in patients with chronic pain and coexistent opioid addiction. J Addict Dis (2013) 0.98
Association between substance use disorder status and pain-related function following 12 months of treatment in primary care patients with musculoskeletal pain. J Pain (2010) 0.98
Risk for prescription opioid misuse among patients with a history of substance use disorder. Drug Alcohol Depend (2012) 0.96
Assessment and treatment of abuse risk in opioid prescribing for chronic pain. Pain Res Treat (2011) 0.95
Opioid use among low back pain patients in primary care: Is opioid prescription associated with disability at 6-month follow-up? Pain (2013) 0.94
Patterns and correlates of prescription opioid use in OEF/OIF veterans with chronic noncancer pain. Pain Med (2011) 0.94
Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Med (2012) 0.88
Self-loathing aspects of depression reduce postoperative opioid cessation rate. Pain Med (2014) 0.86
Integrating pain management in clinical practice. J Clin Psychol Med Settings (2012) 0.84
A Systematic Review of Personality Disorders and Health Outcomes. Can Psychol (2015) 0.82
Healthcare utilization in chronic liver disease: the importance of pain and prescription opioid use. Liver Int (2013) 0.81
Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses. Pain Res Manag (2014) 0.80
Pain medication management of musculoskeletal conditions at first presentation in primary care: analysis of routinely collected medical record data. BMC Musculoskelet Disord (2014) 0.79
Does opioid pain medication use affect the outcome of patients with lumbar disc herniation? Spine (Phila Pa 1976) (2013) 0.78
Factors Associated with Opioid Use in a Cohort of Patients Presenting for Surgery. Pain Res Treat (2015) 0.77
Narcotic analgesic utilization amongst injured workers: using concept mapping to understand current issues from the perspectives of physicians and pharmacists. BMC Health Serv Res (2011) 0.77
Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics. BMJ Open (2016) 0.75
Minimize opioids by optimizing pain psychology. Pain Manag (2014) 0.75
No signs of dose escalations of potent opioids prescribed after tibial shaft fractures: a study of Swedish National Registries. BMC Anesthesiol (2014) 0.75
The many faces of depression in primary care. J Gen Intern Med (2004) 0.75
Incident and long-term opioid therapy among patients with psychiatric conditions and medications: a national study of commercial health care claims. Pain (2017) 0.75
Prescription Opioid Use Among Seriously Mentally Ill Veterans Nationally in the Veterans Health Administration. Community Ment Health J (2015) 0.75
Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology (2006) 3.81
Aversive and reinforcing opioid effects: a pharmacogenomic twin study. Anesthesiology (2012) 2.85
Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain (2012) 2.44
A genetic analysis of opioid-induced hyperalgesia in mice. Anesthesiology (2006) 1.97
Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome. Anesthesiology (2012) 1.64
Gabrb3 gene deficient mice exhibit impaired social and exploratory behaviors, deficits in non-selective attention and hypoplasia of cerebellar vermal lobules: a potential model of autism spectrum disorder. Behav Brain Res (2007) 1.58
No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans. Pain (2009) 1.58
Brain neuroplastic changes accompany anxiety and memory deficits in a model of complex regional pain syndrome. Anesthesiology (2014) 1.56
Peripheral mechanisms of pain and analgesia. Brain Res Rev (2008) 1.55
Management of perioperative pain in patients chronically consuming opioids. Reg Anesth Pain Med (2005) 1.34
The role of interleukin-1 in wound biology. Part II: In vivo and human translational studies. Anesth Analg (2010) 1.32
Sex differences in reported pain across 11,000 patients captured in electronic medical records. J Pain (2012) 1.32
Capsaicin-sensitive sensory neurons contribute to the maintenance of trabecular bone integrity. J Bone Miner Res (2004) 1.22
The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome. Pain (2009) 1.17
The role of interleukin-1 in wound biology. Part I: Murine in silico and in vitro experimental analysis. Anesth Analg (2010) 1.16
Chronic pain and genetic background interact and influence opioid analgesia, tolerance, and physical dependence. Pain (2006) 1.16
The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome. Pain (2009) 1.15
Chronic morphine administration enhances nociceptive sensitivity and local cytokine production after incision. Mol Pain (2008) 1.13
Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I. Pain (2008) 1.12
A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II. Pain (2003) 1.11
Fracture induces keratinocyte activation, proliferation, and expression of pro-nociceptive inflammatory mediators. Pain (2010) 1.09
Role of substance P signaling in enhanced nociceptive sensitization and local cytokine production after incision. Pain (2009) 1.07
Quantitative trait locus and computational mapping identifies Kcnj9 (GIRK3) as a candidate gene affecting analgesia from multiple drug classes. Pharmacogenet Genomics (2008) 1.05
Isoflurane and nociception: spinal alpha2A adrenoceptors mediate antinociception while supraspinal alpha1 adrenoceptors mediate pronociception. Anesthesiology (2002) 1.04
Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice. J Pain (2013) 0.98
Neuropeptides contribute to peripheral nociceptive sensitization by regulating interleukin-1β production in keratinocytes. Anesth Analg (2011) 0.96
Alterations in spinal cord gene expression after hindpaw formalin injection. J Neurosci Res (2004) 0.96
miR-203 regulates nociceptive sensitization after incision by controlling phospholipase A2 activating protein expression. Anesthesiology (2012) 0.96
A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section. Bone (2003) 0.95
The beta2 adrenergic receptor regulates morphine tolerance and physical dependence. Behav Brain Res (2007) 0.95
5-hydroxytryptamine type 3 receptor modulates opioid-induced hyperalgesia and tolerance in mice. Anesthesiology (2011) 0.94
Bone microstructure and its associated genetic variability in 12 inbred mouse strains: microCT study and in silico genome scan. Bone (2007) 0.90
Sympathetic block with botulinum toxin to treat complex regional pain syndrome. Ann Neurol (2009) 0.90
Opioid pharmacogenomics using a twin study paradigm: methods and procedures for determining familial aggregation and heritability. Twin Res Hum Genet (2010) 0.89
Nociceptive sensitization by complement C5a and C3a in mouse. Pain (2009) 0.89
Spinal CK2 regulates nociceptive signaling in models of inflammatory pain. Pain (2005) 0.89
Changes resembling complex regional pain syndrome following surgery and immobilization. J Pain (2013) 0.89
Caspase-1 modulates incisional sensitization and inflammation. Anesthesiology (2010) 0.88
Pharmacological profiles of opioid ligands at kappa opioid receptors. BMC Pharmacol (2006) 0.87
Activation profiles of opioid ligands in HEK cells expressing delta opioid receptors. BMC Neurosci (2002) 0.87
Modulation of the NO/CO-cGMP signaling cascade during chronic morphine exposure in mice. Neurosci Lett (2004) 0.87
Gabrb3 gene deficient mice exhibit increased risk assessment behavior, hypotonia and expansion of the plexus of locus coeruleus dendrites. Brain Res (2006) 0.87
The complement component C5a receptor mediates pain and inflammation in a postsurgical pain model. Pain (2011) 0.87
Formalin-induced spinal cord calcium/calmodulin-dependent protein kinase II alpha expression is modulated by heme oxygenase in mice. Neurosci Lett (2004) 0.87
Expression genetics identifies spinal mechanisms supporting formalin late phase behaviors. Mol Pain (2010) 0.86
Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome. Pain (2013) 0.86
Epigenetic regulation of spinal CXCR2 signaling in incisional hypersensitivity in mice. Anesthesiology (2013) 0.85
Hyperalgesia during opioid abstinence: mediation by glutamate and substance p. Anesth Analg (2002) 0.83
Acute and chronic phases of complex regional pain syndrome in mice are accompanied by distinct transcriptional changes in the spinal cord. Mol Pain (2013) 0.83
Dexmedetomidine fails to cause hyperalgesia after cessation of chronic administration. Anesth Analg (2003) 0.82
Ketamine for managing perioperative pain in opioid-dependent patients with chronic pain: a unique indication? Anesthesiology (2010) 0.81
Curcumin treatment attenuates pain and enhances functional recovery after incision. Anesth Analg (2014) 0.80
Roles of Gr-1+ leukocytes in postincisional nociceptive sensitization and inflammation. Anesthesiology (2012) 0.80
Transcutaneous blood gas CO2 monitoring of induced ventilatory depression in mice. Anesth Analg (2006) 0.80
Spinal cord heme oxygenase participates in glutamate-induced pain-related behaviors. Eur J Pharmacol (2002) 0.79
Heme oxygenase type 2 participates in the development of chronic inflammatory and neuropathic pain. J Pain (2003) 0.79
Understanding our drugs and our diseases. Proc Am Thorac Soc (2006) 0.79
Integrative approach to pain genetics identifies pain sensitivity loci across diseases. PLoS Comput Biol (2012) 0.79
Epigenetic regulation of spinal cord gene expression controls opioid-induced hyperalgesia. Mol Pain (2014) 0.78
Opioid medication management: clinician beware! Anesthesiology (2010) 0.78
Understanding methadone metabolism: a foundation for safer use. Anesthesiology (2008) 0.78
Sleep quality and the role of sleep medications for veterans with chronic pain. Pain Med (2006) 0.77
Dietary methyl content regulates opioid responses in mice. J Pain Res (2013) 0.77
Effects of methyl donor diets on incisional pain in mice. PLoS One (2013) 0.77
Differential Efficacy of Ketamine in the Acute versus Chronic Stages of Complex Regional Pain Syndrome in Mice. Anesthesiology (2015) 0.76
Formalin injection causes a coordinated spinal cord CO/NO-cGMP signaling system response. Mol Pain (2005) 0.76
The role of the extracellular matrix in chronic pain following injury. Pain (2015) 0.76
Capsaicin sensitive afferents mediate the development of heat hyperalgesia and hindpaw edema after sciatic section in rats. Neurosci Lett (2002) 0.75
Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome. Anesth Analg (2016) 0.75
In reply. Anesthesiology (2013) 0.75
Molecular Interaction between Stress and Pain. Anesthesiology (2016) 0.75
Spinal cord stimulation: does frequency matter? Anesthesiology (2013) 0.75
Opioid self-administration: a better way to evaluate analgesics in animal models? Anesthesiology (2007) 0.75
Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy. J Addict Med (2017) 0.75
Nervous system delivery of antilysophosphatidic acid antibody by nasal application attenuates mechanical allodynia after traumatic brain injury in rats. Pain (2017) 0.75
Computational genetic discoveries that could improve perioperative medicine. Curr Opin Anaesthesiol (2012) 0.75